UBS report listed the Buy-rated HK-listed stocks with highest UBS earnings upside above consensus estimate:Shares│UBS vs consensus' comprehensive profit forecast differences for companies in 2025 and 2026CANSINOBIO (06185.HK) -1.050 (-2.344%) Short selling $3.63M; Ratio 3.984% │97%CSPC PHARMA (01093.HK) -0.030 (-0.302%) Short selling $505.63M; Ratio 16.999% │60%3SBIO (01530.HK) -1.900 (-5.919%) Short selling $137.10M; Ratio 6.928% │42%CARSGEN-B (02171.HK) -2.070 (-9.561%) Short selling $6.92M; Ratio 4.732% │42%SHANGHAI PECHEM (00338.HK) -0.060 (-4.317%) Short selling $1.05M; Ratio 3.219% │37%Related NewsBofAS Lifts WUXI APPTEC's TP to HKD115.7, Reiterating Buy RatingYUEXIU PROPERTY (00123.HK) -0.070 (-1.515%) Short selling $9.96M; Ratio 20.375% │35%GOLDWIND (02208.HK) +0.210 (+2.996%) Short selling $6.82M; Ratio 6.141% │33%SKB BIO-B (06990.HK) -10.800 (-2.596%) Short selling $29.61M; Ratio 10.527% │27%CSC (06066.HK) -0.200 (-1.592%) Short selling $16.94M; Ratio 9.796% │26%HENGRUI PHARMA (01276.HK) -3.750 (-4.756%) │25%SITC (01308.HK) +0.300 (+1.179%) Short selling $13.08M; Ratio 9.779% │23%WUXI APPTEC (02359.HK) -4.000 (-3.784%) Short selling $577.63M; Ratio 37.655% │22%(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-08-01 16:25.)